VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

75 hedge funds and large institutions have $180M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$209K
Puts
$2.58M
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$645K
27
$597K
28
$591K
29
$581K
30
$532K
31
$519K
32
$516K
33
$442K
34
$432K
35
$426K
36
$396K
37
$394K
38
$346K
39
$332K
40
$321K
41
$306K
42
$301K
43
$294K
44
$284K
45
$265K
46
$232K
47
$229K
48
$200K
49
$194K
50
$179K
1
2
3